Skip to main content
Erschienen in: European Radiology 2/2013

01.02.2013 | Head and Neck

Diffusion-weighted MR imaging including bi-exponential fitting for the detection of recurrent or residual tumour after (chemo)radiotherapy for laryngeal and hypopharyngeal cancers

verfasst von: Dechen W. Tshering Vogel, Peter Zbaeren, Andreas Geretschlaeger, Peter Vermathen, Frederik De Keyzer, Harriet C. Thoeny

Erschienen in: European Radiology | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To assess whether diffusion-weighted magnetic resonance imaging (DW-MRI) including bi-exponential fitting helps to detect residual/recurrent tumours after (chemo)radiotherapy of laryngeal and hypopharyngeal carcinoma.

Methods

Forty-six patients with newly-developed/worsening symptoms after (chemo)radiotherapy for laryngeal/hypopharyngeal cancers were prospectively imaged using conventional MRI and axial DW-MRI. Qualitative (visual assessment) and quantitative analysis (mono-exponentially: total apparent diffusion coefficient [ADCT], and bi-exponentially: perfusion fraction [FP] and true diffusion coefficient [ADCD]) were performed. Diffusion parameters of tumour versus post-therapeutic changes were compared, with final diagnosis based on histopathology and follow-up. Mann-Whitney U test was used for statistical analysis.

Results

Qualitative DW-MRI combined with morphological images allowed the detection of tumour with a sensitivity of 94% and specificity 100%. ADCT and ADCD values were lower in tumour with values 120 ± 49 × 10−5 mm2/s and 113 ± 50 × 10−5 mm2/s, respectively, compared with post-therapeutic changes with values 182 ± 41 × 10−5 mm2/s (P < 0.0002) and 160 ± 47 × 10−5 mm2/s (P < 0.003), respectively. FP values were significantly lower in tumours than in non-tumours (13 ± 9% versus 31 ± 16%, P < 0.0002), with FP being the best quantitative parameter for differentiation between post-therapeutic changes and recurrence.

Conclusions

DW-MRI in combination with conventional MRI substantially improves detection and exclusion of tumour in patients with laryngeal and hypopharyngeal cancers after treatment with (chemo)radiotherapy on both qualitative and quantitative analysis, with FP being the best quantitative parameter in this context.

Key Points

DW-MRI is increasingly used to detect tumour recurrence.
DW-MRI allows accurate post-treatment recurrence detection in laryngeal or hypopharyngeal cancer
ADC values in recurrent tumour are lower than in benign tissue alterations
Both qualitative and quantitative DW-MRI approaches allow detection of recurrence
DW-MRI can easily be added to daily clinical routine imaging
Literatur
1.
Zurück zum Zitat Zbären P, Weidner S, Thoeny HC (2008) Laryngeal and hypopharyngeal carcinomas after (chemo)radiotherapy: a diagnostic dilemma. Curr Opin Otolaryngol Head Neck Surg 16:147–153PubMedCrossRef Zbären P, Weidner S, Thoeny HC (2008) Laryngeal and hypopharyngeal carcinomas after (chemo)radiotherapy: a diagnostic dilemma. Curr Opin Otolaryngol Head Neck Surg 16:147–153PubMedCrossRef
2.
Zurück zum Zitat Becker M, Burkhardt K, Allal AS, Dulguerov P, Ratib O, Becker CD (2009) Prä- und posttherapeutische Larynxbildgebung. Radiologe 49:43–58PubMedCrossRef Becker M, Burkhardt K, Allal AS, Dulguerov P, Ratib O, Becker CD (2009) Prä- und posttherapeutische Larynxbildgebung. Radiologe 49:43–58PubMedCrossRef
3.
Zurück zum Zitat Nömayr A, Lell M, Sweeney R, Bautz W, Lukas P (2001) MRI appearance of radiation-induced changes of normal cervical tissues. Eur Radiol 11:1807–1817PubMedCrossRef Nömayr A, Lell M, Sweeney R, Bautz W, Lukas P (2001) MRI appearance of radiation-induced changes of normal cervical tissues. Eur Radiol 11:1807–1817PubMedCrossRef
4.
Zurück zum Zitat Brouwer J, Hooft L, Hoekstra OS et al (2008) Systematic review: accuracy of imaging tests in the diagnosis of recurrent laryngeal carcinoma after radiotherapy. Head Neck 30:889–897PubMedCrossRef Brouwer J, Hooft L, Hoekstra OS et al (2008) Systematic review: accuracy of imaging tests in the diagnosis of recurrent laryngeal carcinoma after radiotherapy. Head Neck 30:889–897PubMedCrossRef
5.
Zurück zum Zitat Brouwer J, Bodar EJ, De Bree R et al (2004) Detecting recurrent laryngeal carcinoma after radiotherapy: room for improvement. Eur Arch Oto Rhino Laryngol 261:417–422 Brouwer J, Bodar EJ, De Bree R et al (2004) Detecting recurrent laryngeal carcinoma after radiotherapy: room for improvement. Eur Arch Oto Rhino Laryngol 261:417–422
6.
Zurück zum Zitat de Bree R, van der Putten L, Brouwer J, Castelijns JA, Hoekstra OS, Leemans CR (2009) Detection of locoregional recurrent head and neck cancer after (chemo)radiotherapy using modern imaging. Oral Oncol 45:368–393 de Bree R, van der Putten L, Brouwer J, Castelijns JA, Hoekstra OS, Leemans CR (2009) Detection of locoregional recurrent head and neck cancer after (chemo)radiotherapy using modern imaging. Oral Oncol 45:368–393
7.
Zurück zum Zitat Vandecaveye V, De Keyzer F, Vander Poorten V et al (2006) Evaluation of the larynx for tumor recurrence by diffusion-weighted MRI after radiotherapy: initial experience in four cases. Br J Radiol 79:681–687PubMedCrossRef Vandecaveye V, De Keyzer F, Vander Poorten V et al (2006) Evaluation of the larynx for tumor recurrence by diffusion-weighted MRI after radiotherapy: initial experience in four cases. Br J Radiol 79:681–687PubMedCrossRef
8.
Zurück zum Zitat Zbären P, Christe A, Caversaccio MD, Stauffer E, Thoeny HC (2007) Pretherapeutic staging of recurrent laryngeal carcinoma: clinical findings and imaging studies compared with histopathology. Otolaryngol Head Neck Surg 137:487–491PubMedCrossRef Zbären P, Christe A, Caversaccio MD, Stauffer E, Thoeny HC (2007) Pretherapeutic staging of recurrent laryngeal carcinoma: clinical findings and imaging studies compared with histopathology. Otolaryngol Head Neck Surg 137:487–491PubMedCrossRef
9.
Zurück zum Zitat Lell M, Baum U, Greess H et al (2000) Head and neck tumors: imaging recurrent tumor and post-therapeutic changes with CT and MRI. Eur J Radiol 33:239–247PubMedCrossRef Lell M, Baum U, Greess H et al (2000) Head and neck tumors: imaging recurrent tumor and post-therapeutic changes with CT and MRI. Eur J Radiol 33:239–247PubMedCrossRef
10.
Zurück zum Zitat Abdel Razek AA, Kandeel AY, Soliman N et al (2007) Role of diffusion-weighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and posttreatment changes. AJNR Am J Neuroradiol 28:1146–1152PubMedCrossRef Abdel Razek AA, Kandeel AY, Soliman N et al (2007) Role of diffusion-weighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and posttreatment changes. AJNR Am J Neuroradiol 28:1146–1152PubMedCrossRef
11.
Zurück zum Zitat Thoeny HC (2011) Diffusion-weighted MRI in head and neck radiology: applications in oncology. Canc Imag 10:209–214CrossRef Thoeny HC (2011) Diffusion-weighted MRI in head and neck radiology: applications in oncology. Canc Imag 10:209–214CrossRef
12.
Zurück zum Zitat Vandecaveye V, De Keyzer F, Nuyts S et al (2007) Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys 67:960–971PubMedCrossRef Vandecaveye V, De Keyzer F, Nuyts S et al (2007) Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys 67:960–971PubMedCrossRef
13.
Zurück zum Zitat Thoeny HC, Zumstein D, Simon-Zoula S et al (2006) Functional evaluation of transplanted kidneys with diffusion-weighted and BOLD MR imaging: initial experience. Radiology 241:812–821PubMedCrossRef Thoeny HC, Zumstein D, Simon-Zoula S et al (2006) Functional evaluation of transplanted kidneys with diffusion-weighted and BOLD MR imaging: initial experience. Radiology 241:812–821PubMedCrossRef
14.
Zurück zum Zitat Thoeny HC, Binser T, Roth B, Kessler TM, Vermathen P (2009) Noninvasive assessment of acute ureteral obstruction with diffusion-weighted MR imaging: a prospective study. Radiology 252:721–728PubMedCrossRef Thoeny HC, Binser T, Roth B, Kessler TM, Vermathen P (2009) Noninvasive assessment of acute ureteral obstruction with diffusion-weighted MR imaging: a prospective study. Radiology 252:721–728PubMedCrossRef
15.
Zurück zum Zitat Yamada I, Aung W, Himeno Y, Nakagawa T, Shibuya H (1999) Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology 210:617–623PubMed Yamada I, Aung W, Himeno Y, Nakagawa T, Shibuya H (1999) Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology 210:617–623PubMed
16.
Zurück zum Zitat Lemke A, Laun FB, Klauss M et al (2009) Differentiation of pancreas carcinoma from healthy pancreatic tissue using multiple b-values: comparison of apparent diffusion coefficient and intravoxel incoherent motion derived parameters. Invest Radiol 44:769–775PubMedCrossRef Lemke A, Laun FB, Klauss M et al (2009) Differentiation of pancreas carcinoma from healthy pancreatic tissue using multiple b-values: comparison of apparent diffusion coefficient and intravoxel incoherent motion derived parameters. Invest Radiol 44:769–775PubMedCrossRef
17.
Zurück zum Zitat Lewin M, Fartoux L, Vignaud A, Arrivé L, Menu Y, Rosmorduc O (2011) The diffusion-weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot study. Eur Radiol 21:281–290PubMedCrossRef Lewin M, Fartoux L, Vignaud A, Arrivé L, Menu Y, Rosmorduc O (2011) The diffusion-weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot study. Eur Radiol 21:281–290PubMedCrossRef
18.
Zurück zum Zitat King AD, Mo FK, Yu KH et al (2010) Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response. Eur Radiol 20:2213–2220PubMedCrossRef King AD, Mo FK, Yu KH et al (2010) Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response. Eur Radiol 20:2213–2220PubMedCrossRef
19.
Zurück zum Zitat Vandecaveye V, Dirix P, De Keyzer F et al (2012) Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 82:1098–1107PubMedCrossRef Vandecaveye V, Dirix P, De Keyzer F et al (2012) Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 82:1098–1107PubMedCrossRef
20.
Zurück zum Zitat Thoeny HC, Ross BD (2010) Predicting and monitoring cancer treatment response with diffusion-weighted MRI. J Magn Reson Imaging 32:2–16PubMedCrossRef Thoeny HC, Ross BD (2010) Predicting and monitoring cancer treatment response with diffusion-weighted MRI. J Magn Reson Imaging 32:2–16PubMedCrossRef
Metadaten
Titel
Diffusion-weighted MR imaging including bi-exponential fitting for the detection of recurrent or residual tumour after (chemo)radiotherapy for laryngeal and hypopharyngeal cancers
verfasst von
Dechen W. Tshering Vogel
Peter Zbaeren
Andreas Geretschlaeger
Peter Vermathen
Frederik De Keyzer
Harriet C. Thoeny
Publikationsdatum
01.02.2013
Verlag
Springer-Verlag
Erschienen in
European Radiology / Ausgabe 2/2013
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-012-2596-x

Weitere Artikel der Ausgabe 2/2013

European Radiology 2/2013 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.